SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0001209191-17-004484
Filing Date
2017-01-19
Accepted
2017-01-19 16:31:07
Documents
1
Period of Report
2016-10-25

Document Format Files

Seq Description Document Type Size
1 FORM 3/A SUBMISSION doc3a.html 3/A  
1 FORM 3/A SUBMISSION doc3a.xml 3/A 2584
  Complete submission text file 0001209191-17-004484.txt   4022
Mailing Address 35 GATEHOUSE DRIVE WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE WALTHAM MA 02451 781-996-4300
Cerulean Pharma Inc. (Issuer) CIK: 0001401914 (see all company filings)

IRS No.: 204139823 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CERULEAN PHARMA INC. 35 GATEHOUSE DRIVE WALTHAM MA 02451
Business Address
Eliasof Scott (Reporting) CIK: 0001688065 (see all company filings)

Type: 3/A | Act: 34 | File No.: 001-36395 | Film No.: 17536240